AT
Andrew Tsai Jefferies Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
68%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
70.6%
Neutral
29.4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Real Estate
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Real Estate
Real Estate Services
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Downgraded
| $0.9000 |
28%
upside
| 1 | – |
–
| 17 Dec ‘25 22 days ago |
|
|
|
Hold
Initiated
| $30 |
11%
downside
| 1 | – |
–
| 12 Dec ‘25 27 days ago |
|
|
|
Buy
Maintained
| $450 |
53%
upside
| 2 | +191% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Buy
Initiated
| $32 |
86%
upside
| 1 | +29% |
0
%
| 21 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $25 |
57%
upside
| 1 | +19% |
0
%
| 12 Nov ‘25 1 month ago |
|
|
|
Hold
Downgraded
| $20 |
7%
downside
| 1 | – |
–
| 22 Oct ‘25 2 months ago |
|
|
|
Hold
Downgraded
| $56 | – | 1 | – |
–
| 9 Oct ‘25 3 months ago |
|
|
|
Buy
Initiated
| $190 |
2%
upside
| 1 | +35% |
0
%
| 25 Sep ‘25 3 months ago |
|
|
|
Buy
Maintained
| $35 |
51%
upside
| 2 | +5.3% |
0
%
| 24 Jul ‘25 5 months ago |
|
|
|
Buy
Initiated
| $30 |
11%
downside
| 1 | +173% |
0
%
| 18 Jul ‘25 5 months ago |
|
|
|
Buy
Initiated
| $70 |
5%
downside
| 1 | +59% |
0
%
| 14 Jul ‘25 5 months ago |
|
|
|
Buy
Maintained
| $110 | – | 1 | +23% |
0
%
| 11 Jun ‘25 7 months ago |
|
|
|
Hold
Downgraded
| $2.50 |
36%
downside
| 1 | -80% |
–
| 28 May ‘25 7 months ago |
|
|
|
Buy
Initiated
| $200 |
19%
upside
| 1 | +69% |
0
%
| 7 Apr ‘25 9 months ago |
|
|
|
Overweight
Maintained
| $27 |
56%
upside
| 1 | -26% |
0
%
| 19 Mar ‘25 9 months ago |
|